Master by Research (MRes) is a one-year research-focused postgraduate programme delivered at the Institute of Cancer Therapeutics.
The ICT is world-renowned for cancer research, training, and partnerships with industry. The MRes Drug Development will provide you with the opportunity to undertake a major research project in one of our research groups.
The programme is designed for students who wish to undertake a PhD degree or those who wish to enter employment in an advanced capacity in industry or the public sector in the field of life sciences.
Entry requirements
An undergraduate Honours qualification (minimum 2: 1) or equivalent in a scientific discipline, usually within chemistry, biology, pharmacy, biomedicine, or related fields. Candidates with a 2:2 or equivalent degree who can show relevant experience will also be considered.
For North American students a GPA of normally 2.5 and above (on a scale of 4.0), or an equivalent, is required.
A levels
Entry to this programme requires a pass at A level Chemistry OR having taken an undergraduate module in a relevant chemical subject.
English language requirements
If your native language is not English, or the official language of your first degree is not English, you will need to pass a test in English approved by the University before you can be admitted. The International English Language Testing System test (IELTS) administered by the British Council is the test which is preferred by the University.
You will need to achieve an overall score of at least 6.0, with at least 5.5 in each of the four sub-tests (speaking, listening, reading, writing). Testing facilities are available at most British Council overseas offices. When you take the test, you should ask for a copy of your Test Report Form to be sent to the University.
What you will study
All module information is for 2024 and is subject to change.
The programme consists of three components, adding to the total of 180 credits required to complete a Master's degree.
Research Skills (30 credits): This module aims to provide a foundation in the laboratory and scientific transferable skills necessary for you to study, research and communicate topics in cancer therapeutics development. The material in this module is designed to equip you with the skills you need for the later stages of the course.
Specialist Module (30 credits): You will take an optional taught module selected between Cancer Drug Discovery or Drug Toxicology and Safety Pharmacology, depending on the route you would like to specialise in.
Research project module (120 credits): You will join a research group at the ICT to undertake a major research project. The programme recently introduced an industrial placement element where you can spend part or all of your training in an industrial setting, too. The project will be supervised individually and enable you to gain hands-on experience in original research.
Fees, finance and scholarships
Tuition fee
2025
Home: £9,698
International: £25,389
Additional costs
There may be additional costs that you may incur as a student. Though these are not essential to your programme of study you need to be aware of them as a student of the University. A list of the sort of costs you might expect can be found on our fees and finance section.
Every year we award numerous non-repayable scholarships to UK, EU and international students on the basis of academic excellence, personal circumstances or economic hardship. For full details, visit our scholarships section.
This is the current course information. Modules and course details may change, subject to the University's programme approval, monitoring and review procedures. The University reserves the right to alter or withdraw courses, services and facilities as described on our website without notice and to amend Ordinances, Regulations, fees and charges at any time. Students should enquire as to the up-to-date position when applying for their course of study.